Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianjin Capsule combined with antibiotics for PID
NCT04031664Phase 4Unknown
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Aug 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Fuke Qianjin in pelvic inflammatory disease (PID), sponsored by China Academy of Chinese Medical Sciences. Status: unknown.
02
Drugs
Fuke Qianjin
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT04031664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031664.